Systemic arterial hypertension is one of the major causes of morbidity and mortality in the U.S. , affecting more than 30 million Americans. At this time, the etiology of """"""""essential"""""""" hypertension remains unknown. The goal of the present proposal is to investigate the role of the Na/H exchanger, a ubiquitous transmembrane transport protein, in essential hypertension. Because of its role in both growth and Na regulation, the Na/H exchanger has been proposed as a logical mediator of abnormal vascular smooth muscle cell (VSMC) function in hypertension. Indeed, our laboratory has reported that VSMC from the Spontaneously Hypertensive Rat (SHR) demonstrate increased Na/H exchange activity and growth. Because we have prepared cDNAs and antibodies for the rat Na/H exchanger, it should be possible to determine the mechanisms that regulate Na/H exchange activity. We propose to define the mechanisms that regulate Na/H exchanger gene expression and function in VSMC to gain insight into the regulatory proteins that are altered in hypertension. The primary hypothesis underlying this proposal is that altered regulation of the Na/H exchanger contributes to pathophysiologic VSMC function. Published data from our laboratory show that steady state exchanger mRNA levels are markedly increased by growth factors, suggesting that it is a growth-regulated gene. To study Na/H exchanger regulation in VSMC these aims are proposed. 1: Isolate fulllength cDNA clones for the rat Na/H exchanger. 2: Determine the relative contributions of transcriptional regulatory mechanisms to the regulation of Na/H exchanger mRNA levels in growth-arrested and proliferating VSMC. 3: Determine the signal transduction mechanisms responsible for hormonal regulation of Na/H exchanger gene expression focusing on the role of protein kinase C and transforming growth factor-&. 4: Analyze the mechanisms for regulation of Na/H exchanger protein expression and function in VSMC by measurement of protein synthetic rate and phosphorylation of the exchanger. The experiments in this aim will use anti-peptide antibodies already characterized and transfection of exchange deficient VSMC mutants. 5: Compare the properties of the Na/H exchanger in VSMC from hypertensive (SHR) and normotensive (WKY) rats. The results of these studies should provide a detailed understanding of the mechanisms that regulate Na/H exchanger function in vascular smooth muscle and may provide insights into new therapeutic approaches to treat hypertension.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL044721-03
Application #
3363545
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Project Start
1991-08-01
Project End
1993-12-31
Budget Start
1993-08-01
Budget End
1993-12-31
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Emory University
Department
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Maekawa, Naoya; Abe, Jun-ichi; Shishido, Tetsuro et al. (2006) Inhibiting p90 ribosomal S6 kinase prevents (Na+)-H+ exchanger-mediated cardiac ischemia-reperfusion injury. Circulation 113:2516-23
Itoh, Seigo; Ding, Bo; Shishido, Tetsuro et al. (2006) Role of p90 ribosomal S6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium. Circulation 113:1787-98
Jin, Z G; Berk, B C (2004) SOXF: redox mediators of vascular smooth muscle cell growth. Heart 90:488-90
Osawa, Masaki; Itoh, Seigo; Ohta, Shinsuke et al. (2004) ERK1/2 associates with the c-Met-binding domain of growth factor receptor-bound protein 2 (Grb2)-associated binder-1 (Gab1): role in ERK1/2 and early growth response factor-1 (Egr-1) nuclear accumulation. J Biol Chem 279:29691-9
Akaike, Masashi; Che, Wenyi; Marmarosh, Nicole-Lerner et al. (2004) The hinge-helix 1 region of peroxisome proliferator-activated receptor gamma1 (PPARgamma1) mediates interaction with extracellular signal-regulated kinase 5 and PPARgamma1 transcriptional activation: involvement in flow-induced PPARgamma activation in end Mol Cell Biol 24:8691-704
Jin, Z G; Berk, B C (2004) Role of secreted oxidative stress-induced factors (SOXFs) in the pathogenesis of atherosclerosis. Arch Mal Coeur Vaiss 97:1256-9
Cavet, Megan E; Lehoux, Stephanie; Berk, Bradford C (2003) 14-3-3beta is a p90 ribosomal S6 kinase (RSK) isoform 1-binding protein that negatively regulates RSK kinase activity. J Biol Chem 278:18376-83
Takeishi, Yasuchika; Huang, Qunhua; Abe, Jun-ichi et al. (2002) Activation of mitogen-activated protein kinases and p90 ribosomal S6 kinase in failing human hearts with dilated cardiomyopathy. Cardiovasc Res 53:131-7
Huang, Qunhua; Lerner-Marmarosh, Nicole; Che, Wenyi et al. (2002) The novel role of the C-terminal region of SHP-2. Involvement of Gab1 and SHP-2 phosphatase activity in Elk-1 activation. J Biol Chem 277:29330-41
Che, Wenyi; Lerner-Marmarosh, Nicole; Huang, Qunhua et al. (2002) Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression. Circ Res 90:1222-30

Showing the most recent 10 out of 35 publications